Published online before print February 9, 2007, doi: 10.1161/01.RES.0000260171.52224.6b
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2007 American Heart Association, Inc.
Molecular Medicine |
Deoxymyoglobin Is a Nitrite Reductase That Generates Nitric Oxide and Regulates Mitochondrial Respiration
From the Vascular Medicine Branch (S.S., Z.H., R.G., J.S., L.A.R., P.H.M., X.X., E.M., M.T.G.), NHLBI and CCMD (M.T.G.), Clinical Center; National Institutes of Health, Bethesda, Md; and Department of Cellular and Molecular Pathology (V.M.D.-U.), Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham.
Correspondence to Dr Mark T. Gladwin, National Institutes of Health, Building 10-CRC, Room 5–5410, Bethesda, MD 20892-1662. E-mail mgladwin{at}nih.gov
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Previous studies have revealed a novel interaction between deoxyhemoglobin and nitrite to generate nitric oxide (NO) in blood. It has been proposed that nitrite acts as an endocrine reservoir of NO and contributes to hypoxic vasodilation and signaling. Here, we characterize the nitrite reductase activity of deoxymyoglobin, which reduces nitrite approximately 36 times faster than deoxyhemoglobin because of its lower heme redox potential. We hypothesize that physiologically this reaction releases NO in proximity to mitochondria and regulates respiration through cytochrome c oxidase. Spectrophotometric and chemiluminescent measurements show that the deoxymyoglobin-nitrite reaction produces NO in a second order reaction that is dependent on deoxymyoglobin, nitrite and proton concentration, with a bimolecular rate constant of 12.4 mol/L–1s–1 (pH 7.4, 37°C). Because the IC50 for NO-dependent inhibition of mitochondrial respiration is approximately 100 nmol/L at physiological oxygen tensions (5 to 10 µmol/L); we tested whether the myoglobin-dependent reduction of nitrite could inhibit respiration. Indeed, the addition of deoxymyoglobin and nitrite to isolated rat heart and liver mitochondria resulted in the inhibition of respiration, while myoglobin or nitrite alone had no effect. The addition of nitrite to rat heart homogenate containing both myoglobin and mitochondria resulted in NO generation and inhibition of respiration; these effects were blocked by myoglobin oxidation with ferricyanide but not by the xanthine oxidoreductase inhibitor allopurinol. These data expand on the paradigm that heme-globins conserve and generate NO via nitrite reduction along physiological oxygen gradients, and further demonstrate that NO generation from nitrite reduction can escape heme autocapture to regulate NO-dependent signaling.
Key Words: nitrite • myoglobin • mitochondria
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Recent studies have established a role for nitrite as an endocrine storage pool of NO that can be bioactivated along the physiological oxygen gradient to mediate a number of responses, including hypoxic vasodilation,1–4 cytoprotection following ischemia/reperfusion,5,6 and NO-dependent and independent signaling.7 Several mechanisms for nitrite conversion to NO have been described including enzymatic reduction by xanthine oxidoreductase,8 the mitochondria9 and NO synthase (NOS),10 as well as nonenzymatic acidic disproportionation.11,12 We have described nitrite-dependent vasodilation in vitro1,2 and in vivo1 associated with nitrite reduction by deoxyhemoglobin, consistent with a reaction first characterized by Brooks13 and Doyle14:
|
|
Nitrite is reduced to NO by deoxyhemoglobin, oxidizing hemoglobin in the process. This reaction possesses both pH and oxygen sensor chemistry because of its requirement for deoxygenated hemoglobin and a proton.15 NO generated from the reaction binds to unreacted hemoglobin to form iron-nitrosyl hemoglobin by the following reaction:
|
|
Furthermore, this reaction is regulated by the allosteric structural conformation of hemoglobin, such that the maximal rate of nitrite reduction occurs at the transition of R (oxy) to T (deoxy) state, around the P50 of hemoglobin.15,16 This is reflected in the fact that the bimolecular rate constant varies over the reaction time as the allosteric conformation of the hemoglobin molecule changes, such that R state hemoglobin has a bimolecular rate constant of 6 mol/L–1 s–1 whereas the constant for T state is 0.12 mol/L–1 s–1, giving the reaction an average bimolecular rate constant of 0.35 mol/L–1 s–1.(pH 7.4, 25oC).15 Mechanistically, the lower heme redox potential in the R-state oxygenated conformation of hemoglobin is associated with an equilibrium distribution of heme electrons that thermodynamically favor the reduction of nitrite. Notably, myoglobin possesses a significantly lower heme redox potential than R-state hemoglobin and we found that deoxymyoglobin reduced nitrite and generated NO at a faster rate than deoxyhemoglobin, in a similar manner to what has been described for the reduction of S-nitrosoglutathione by deoxyhemoglobin and myoglobin.15,17
NO regulates a number of hypoxic signaling responses including mitochondrial respiration18–20 and biogenesis,21 expression of hypoxia inducible factor -1,22,23 and angiogenesis.24 Although myoglobin is thought to limit NO bioavailability in tissues because of its rapid reaction with NO, in hypoxic tissue myoglobin-dependent nitrite reduction may provide a mechanism by which NO is generated to regulate these responses when NOS becomes oxygen limited. We sought to determine whether the paradigm of heme-based nitrite reduction could be extended beyond hemoglobin to myoglobin in tissue. Here, we test the hypothesis that myoglobin reduces nitrite to bioavailable NO which is able to modulate mitochondrial respiration through the inhibition of cytochrome c oxidase. We characterize the nitrite-deoxymyoglobin reaction and show that the reduction of nitrite by deoxymyoglobin generates NO that can inhibit mitochondrial respiration in isolated mitochondria, cardiomyocytes, and heart homogenates.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Hemoglobin and Myoglobin
Human hemoglobin was prepared as previously described.15 Oxygen saturation and concentration of hemoglobin and horse heart myoglobin were measured by visible absorption spectroscopy.
Determination of the Product Yields of the Nitrite-Myoglobin Reaction
The kinetics of the nitrite-deoxyheme reaction and the concentration of each heme species was monitored spectrophotometrically and analyzed by least-squares deconvolution using standard reference spectra as previously described.15
Animals
Mitochondria and tissue were isolated from male Sprague-Dawley rats 250 to 300 g in weight which were treated in compliance with the guidelines of the animal care and use committee of NIH.
Mitochondrial Isolation and Respiration
Mitochondria were isolated by differential centrifugation as previously described19 and protein concentration determined using the Bradford Assay. To measure respiration, protein was suspended in respiration buffer [KCl (120mmol/L); sucrose (25mmol/L); HEPES (10 mmol/L); EGTA (1 mmol/L); KH2PO4 (1 mmol/L); MgCl2 (5mmol/L)] in a stirred, sealed chamber fit with a Clark type oxygen electrode (Instech Corp, Plymouth, Mass) connected to a data recording device (DATAQ systems, Akron, Ohio).
Isolation and Respiration of Cardiomyocytes
Cardiomyocytes were isolated from rats as previously described.25 To measure respiration, myocytes were suspended in media 199 at 
109 cells/mL with 3 µmol/L Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP).
Measurement of NO Generation
Nitrite (5 mmol/L) was reacted with deoxymyoglobin (35 µmol/L) in a stirred flask under anaerobic conditions at 37°C and the headspace was purged with helium with outflow to the NO chemiluminescence analyzer (Sievers, GE Analytical Instruments) as previously described.15
NO production from tissue homogenate (1 to 3 mg) with nitrite (1 mmol/L) was measured in a vessel in which the solution and headspace was purged with helium and connected in line to a NO chemiluminescence analyzer.
For an expanded Materials and Methods, please see the online data supplement available at http://circres.ahajournals.org.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Deoxymyoglobin Is a Nitrite Reductase That Generates NO and Is Regulated by pH
We have previously shown that the reaction of nitrite with deoxymyoglobin is a second order reaction with a bimolecular rate constant of 6 mol/L–1s–1 (25°C, pH 7.4).15 To further characterize this reaction, we monitored the disappearance of deoxymyoglobin as well as the formation of total metmyoglobin (the sum of metmyoglobin and nitrite bound metmyoglobin) and iron-nitrosyl-myoglobin over the time course of the reaction (Figure 1A).
|
Whereas examination of equations 1 and 2
would suggest that 1 nitrite reacting with 1 deoxymyoglobin would produce 1 metmyoglobin and iron-nitrosyl-myoglobin, work by other investigators suggests that the reaction would produce more metmyoglobin than iron-nitrosyl myoglobin, and that this nonstoichiometric product yield occurs secondary to NO-metmyoglobin formation.26 This is important because the reactions described in equations 1 and 2 would generate only NO whereas NO-metmyoglobin could generate NO+-ferrous myoglobin, which could nitrosate thiols. We examined these reactions and found that the product yields are actually stoichiometric (Figure 1A and B) with 1 nitrite reacting with 1 deoxymyoglobin to produce 1 metmyoglobin and NO (equation 1), which subsequently binds to one deoxymyoglobin to form one iron-nitrosyl-myoglobin (equation 2). Whereas we saw a slightly higher yield of metmyoglobin when low concentrations of nitrite were used, this was because of the autooxidation of deoxymyoglobin. We observed that 2% of deoxymyoglobin was oxidized to metmyoglobin over 1000 seconds in the absence of nitrite.
To examine the stoichiometry of the reaction we performed least-squares deconvolution over the reaction time and included standard spectra for deoxymyoglobin, iron-nitrosyl-myoglobin, metmyoglobin, nitrite-metmyoglobin (nitrite bound to metmyoglobin), and NO-metmyoglobin (the putative intermediate considered by other investigators26,27). As shown in Figure 1B, virtually no NO-metmyoglobin forms during the reaction, but rather nitrite-metmyoglobin forms. We therefore included nitrite-metmyoglobin and NO-metmyoglobin reference spectra in our analysis and compared the 
2 values over time. The inclusion of nitrite-metmyoglobin resulted in significantly lower residuals than NO-metmyoglobin (Figure 1C). These data suggest that NO free radical, rather than NO+-ferrous myoglobin, is the primary species generated and that no stable NO-metmyoglobin intermediate forms.
As expected, with an increase in temperature from 25o to 37°C we observed an increase in the bimolecular rate constant (from 6 to 12 mol/L–1s–1) (data not shown). Further kinetic analysis of the reaction showed expected increases in the initial reaction rate when either nitrite (0 to 5mmol/L) or deoxymyoglobin concentration was increased (Figure 1D and E). The bimolecular rate constants calculated from each of the conditions in Figure 1D and E were in agreement with one another and averaged 12.83±0.157 and 12.86±0.429 mol/L–1s–1 respectively.
Deoxymyoglobin dependent nitrite reduction requires a proton and hence should be regulated by pH, with reaction rate increasing by 10 fold with each decrease in pH unit. Indeed, as pH was lowered the initial reaction rate of deoxymyoglobin (29 µmol/L) and nitrite (0.5 mmol/L), increased from 0.065 µmol/L/s at pH 7.8 to 1.30 µmol/L/s at pH 6.5 (Figure 1F).
Deoxymyoglobin-Dependent Nitrite Reduction Generates NO Gas
We compared the formation of NO from the reaction of deoxymyoglobin and deoxyhemoglobin (35 µmol/L) with nitrite (5 mmol/L) (Figure 2A). Because of their different reaction rates (Figure 2A, inset), the NO generation profiles for hemoglobin and myoglobin differ. NO generation from myoglobin occurs quickly as a large burst; whereas hemoglobin-dependent NO generation is much slower and peaks at the T-to-R allosteric transition.15
|
In this experiment, supraphysiological nitrite concentrations were used to measure NO gas accumulation in the head space over a short period of time. However, the calculated rate of NO generated for physiological concentrations of myoglobin (25 µmol/L) and nitrite (20 µmol/L) is 3.5 nM/second at pH 7.4 and 37°C. This rate of conversion of nitrite to NO should produce sufficient concentrations of NO to inhibit mitochondrial respiration within ten to twenty seconds at neutral pH and only a few seconds at pH 6.4.
Deoxymyoglobin Dependent Reduction of Nitrite Regulates Mitochondrial Respiration
Nitric oxide is a well characterized modulator of mitochondrial function, with physiologic concentrations regulating respiration,28,29 biogenesis,21 cytochrome c release30 and reactive oxygen species production.31,32 The best characterized effect of NO on mitochondria is the binding of NO to cytochrome c oxidase to inhibit respiration. This reversible inhibition is more potent as oxygen concentration decreases (IC50=140 nmol/L at 5 to 10 µmol/L O2) and is thought to limit hypoxic tissue damage by the extension of tissue oxygen gradients.18–20
We hypothesized that NO produced by the myoglobin-dependent reduction of nitrite could inhibit mitochondrial respiration. However, because myoglobin must be at least partially deoxygenated (which occurs below its P50 of 3.1 µmol/L oxygen), we developed a method to measure inhibition of respiration at low oxygen concentration. Using a Clark-type oxygen electrode in a sealed chamber, mitochondria (2 mg/mL) were stimulated to respire by the addition of succinate (15mmol/L) and ADP (1 mmol/L). Once the chamber was made anoxic by allowing the mitochondria to consume the oxygen in the chamber, the chamber lid was removed to allow diffusion of air back into the buffer. However, even with the diffusion of air into the stirred chamber, the chamber remained anoxic because of the constant rate of oxygen consumption by the mitochondria exceeding the rate of oxygen diffusion into the chamber. The chamber remained at zero oxygen tension until the respiratory rate decreased either because of the exhaustion of substrate (in control mitochondria) or the addition of a respiratory inhibitor such as cyanide (20 µmol/L) or NO (10 µmol/L Papa NONOate) (Figure 2B). In this model, the time from the equilibration of mitochondria with air to the time at which an increase in the oxygen concentration in the chamber was detected by the electrode was used as a measure of the extent of mitochondrial inhibition. With complete inhibition of respiration in the presence of cyanide (20 µmol/L), the time from equilibration to increase in the respiratory trace was 42±8 seconds, whereas in the absence of an inhibitor, this time was 182±23 seconds. Using the time to inhibition in the presence (100% inhibition) and absence (0% inhibition) of cyanide, inhibition in other conditions was expressed as a percentage of total inhibition (extent of inhibition). For example, in the presence of the NO donor PapaNONOate (10µmol/L), the extent of inhibition is 81±7% consistent with partial inhibition by NO. It is important to note that in this system the time to inhibition reflects the time necessary for oxygen diffusion into the buffer and detection by the oxygen electrode and does not represent instantaneous inhibition.
To determine whether deoxymyoglobin dependent nitrite reduction could produce NO capable of inhibiting respiration, mitochondrial respiration was stimulated in the presence of oxygenated myoglobin (25 µmol/L). Once the chamber became anoxic and the myoglobin deoxygenated, nitrite (20 µmol/L) was added and diffusion of air into the chamber was initiated. In this case, the mitochondria were inhibited by 79±9%, whereas respiration in the presence of nitrite (20 µmol/L) (9±7%) or myoglobin (25 µmol/L) (9.8±5.5%) alone was not significantly inhibited in comparison to control mitochondria (Figure 2C and D). The addition of superoxide dismutase (50 U/mL) and catalase (50 U/mL) or the lipid soluble antioxidant butylated hydroxytoluene (100 µmol/L) did not significantly change the extent of inhibition in the presence of nitrite and myoglobin, indicating that neither oxygen nor NO consumption by superoxide or lipid peroxidation played a significant role in this system. The use of oxidized myoglobin (metmyoglobin, 20 µmol/L) instead of oxymyoglobin did not inhibit respiration, consistent with the inability of metmyoglobin to reduce nitrite (Figure 2D). Isolated heart mitochondria (2 mg/mL) were also inhibited in the presence of nitrite (20 µmol/L) and myoglobin (25 µmol/L) together (83±5%) but not by myoglobin (3.5±9%) or nitrite (6.8±5%) alone (Figure 2E).
The inhibition of respiration with increasing myoglobin concentration (0 to 100 µmol/L) in the presence of nitrite (25 µmol/L) was biphasic with the greatest inhibition occurring at 25 µmol/L of myoglobin (Figure 3A). Nitric oxide binds to deoxymyoglobin with a rate of 1.7x107 M–1s–1 and to cytochrome c oxidase at a similar rate (1.0x107 M–1s–1), suggesting that an efficient competition is established between the mitochondria and myoglobin for NO. Hence, in conditions of excess myoglobin, myoglobin can successfully "outcompete" mitochondria for NO. The biphasic curve seen with increased myoglobin concentration is most probably because of this autocapture of NO by myoglobin. The extent of inhibition (in the presence of 25 µmol/L myoglobin) was also dependent on the concentration of nitrite (0 to 50 µmol/L) (Figure 3B and C). Notably, at concentrations above 50 µmol/L, nitrite had myoglobin independent inhibitory effects on mitochondria, consistent with studies showing that nitrite bound to cytochrome c oxidase results in inhibition of respiration33,34 as well as the ability of mitochondria to reduce high concentrations of nitrite to NO independent of myoglobin.9
|
Inhibition of Respiration by Deoxygenated Myoglobin, Hemoglobin, and Erythrocytes Is Determined by Their Nitrite Reductase Rates
Although hemoglobin and myoglobin reduce nitrite by the same reaction, their reduction rates are different.15 The rate of hemoglobin dependent nitrite reduction is regulated by the allosteric transition of hemoglobin and the bimolecular rate constant for T-state deoxyhemoglobin is 0.39 mol/L–1s–1. Because of its lower heme reduction potential, the rate of myoglobin-dependent nitrite reduction is 32 times faster than hemoglobin. The bimolecular rate constant of T-state deoxyhemoglobin encapsulated in erythrocytes is reduced by approximately half (0.18 mol/L–1s–1) in comparison to cell free hemoglobin, because of membrane effects that decrease the rate of nitrite uptake.1,2 Because of their different reaction rates (Figure 2A) the NO generation profiles for these different proteins also differ, with NO production from hemoglobin occurring at a slower rate.
Comparison of the rate of mitochondrial inhibition for hemoglobin (50 µmol/L), myoglobin (50 µmol/L), and erythrocytes (0.3% hematocrit) in the presence of nitrite (20 µmol/L) showed that whereas all 3 forms of deoxyheme were capable of inhibiting mitochondrial respiration in the presence of nitrite, the extent of inhibition was significantly different. The extent of inhibition correlated with measured nitrite reduction and NO production rates from the reactions (Figure 4A and B). As expected, myoglobin was the most potent inhibitor of respiration (54±8% inhibited) followed by cell free hemoglobin (38±9%) and then erythrocytes (19±9%).
|
Nitrite Inhibits Mitochondrial Respiration in Heart Homogenates
Whereas we have shown that isolated myoglobin can reduce nitrite to NO, it is important to determine whether myoglobin-dependent NO generation can occur in a physiological environment with other proteins present. To test this, NO generation was measured by chemiluminescence in rat heart homogenate (1 mg/mL) in the presence and absence of nitrite (1 mmol/L). Consistent with previous studies,6 when nitrite was added to the homogenate under anaerobic conditions NO (12.1±2 nmol/min/mg) was detected, whereas no NO was generated in the absence of nitrite (Figure 5A). Previous studies have shown that enzymatic reduction of nitrite by xanthine oxidoreductase is responsible for a significant portion of tissue dependent nitrite reduction.6,12 However, in these experiments, treatment of tissue with an inhibitor of xanthine oxidase, allopurinol (100 µmol/L), showed minimal change in NO production by the heart (10.3±4.0 nmol/min/mg; Figure 5A and 5B). Treatment of the heart homogenate with ferricyanide (1mmol/L) to oxidize myoglobin decreased NO production by approximately 65% (4.2±1.5 nmol/min/mg; Figure 5A and 5B).
|
We also measured NO production from nitrite in lung homogenate, which contains minimal amounts of myoglobin. Addition of nitrite to the lung generated NO (6.2±2.1 nmol/min/mg), and this rate was unchanged (5.9±3.2 nmol/min/mg) by treatment with ferricyanide (5mmol/L), consistent with the lack of myoglobin in the tissue. In contrast to the heart, allopurinol (100 µmol/L) decreased the NO production in lung homogenate by approximately 33%. These data are consistent with the predominant nitrite reductase in the heart being myoglobin, whereas in the lung, other nitrite reductases, including xanthine oxidoreductase, playing a role.
To determine whether the NO production seen by chemiluminescence could regulate mitochondrial respiration, respiration was monitored in rat heart homogenates (4 mg/mL protein) in the presence and absence of nitrite. In the presence of nitrite (40 µmol/L), the extent of inhibition was significantly greater (64±3%) than in the absence of nitrite (Figure 5C and D). Whereas no significant effect was seen at nitrite concentrations below 40 µmol/L, this may be because of the insensitivity of our system which requires significant inhibition, the presence of high concentrations of myoglobin, or the loss of compartmentalization of mitochondria and myoglobin in the homogenate. Interestingly, whereas treatment of the homogenate with allopurinol (100 µmol/L) alone increased the extent of inhibition by approximately 10% in comparison to tissue alone, there was no change in the extent inhibition in the presence of nitrite and allopurinol (65±4%). These data again suggest that the majority of nitrite-dependent inhibition of respiration in the tissue homogenate is independent of xanthine oxidoreductase.
Low Concentrations of Nitrite Inhibit Respiration in Cardiomyocytes
To determine the effect of membrane barriers on nitrite-dependent regulation of mitochondrial respiration, we used intact isolated cardiomyocytes which contain high concentrations of both myoglobin and mitochondria. We monitored respiration of the intact myocytes (109 cell/mL) in the presence and absence of nitrite and found that nitrite inhibited respiration in a concentration dependent manner (Figure6A and B). Interestingly, myocytes were even more sensitive to nitrite than isolated mitochondria or heart homogenate, with nitrite concentrations as low as 2.5 µmol/L significantly inhibiting respiration (17.2±3.2%) compared with the absence of nitrite. These data not only suggest that nitrite can enter the myocyte, but also that compartmentalization of mitochondria and myoglobin within the myocyte plays an important role in the nitrite-dependent modulation of respiration.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We have shown here that deoxymyoglobin is an efficient nitrite reductase with a bimolecular rate constant of 12 mol/L–1s–1 at 37°C that generates bioavailable NO. Nitric oxide generated from the reaction of physiological concentrations of myoglobin and nitrite during hypoxia can inhibit respiration in isolated mitochondria in a manner that is dependent on the concentration of both nitrite and myoglobin. Furthermore, this reaction is regulated by oxygen and occurs during hypoxia when oxygen concentration falls below the p50 of myoglobin (2 to 4 mm Hg). This is particularly relevant in organs such as the heart and skeletal muscle where cells remain hypoxic physiologically. To that end, we have shown here that in heart homogenate and isolated cardiomyocytes, the addition of nitrite generates NO and inhibits mitochondrial respiration.
Several earlier studies demonstrated that deoxyhemoglobin-dependent reduction of nitrite mediates biological responses.1,2 This reaction produces vasodilation, generates cGMP, inhibits mitochondrial respiration, and generates NO.1,2 The present study extends this paradigm to myoglobin. Furthermore, the ability of myoglobin-dependent reduction of nitrite to inhibit mitochondrial respiration highlights the ability of NO to escape autocapture by vicinal heme groups. Indeed, in many of these experiments, approximately 20 µmol/L nitrite reacts with an excess of myoglobin (25 to 100 µmol/L) to inhibit respiration; despite the fact that in the time frame of these reactions much of the myoglobin remains reduced and remains capable of reaction with the formed NO. The ability of nitrite to inhibit respiration in tissue homogenate and intact cardiomyocytes is integral to this point because these data demonstrate that even in the presence of other tissue components the NO generated is able to inhibit mitochondria before being scavenged.
The physiological implications of these data should be considered in the context of hypoxic signaling within tissue. Oxygen is a requisite substrate for the production of NO by NOS (km=100 µmol/L).35 We have recently shown that NO produced in normoxia reacts with the multicopper oxidase ceruloplasmin, which oxidizes the NO to nitrite.36 As oxygen tension decreases and oxygen becomes limiting for NOS-dependent NO formation, this nitrite reservoir can be reduced to NO by reactions with deoxymyoglobin. This would ensure a constant supply of NO production along a large gradient of oxygen tensions in the tissue. This myoglobin-dependent reduction of nitrite would be further enhanced when tissue pH drops, accelerating the reaction. This pathway is likely to be physiologically relevant as oxygen concentrations within the subendocardium of the mammalian heart decrease to 4 mm Hg during ventricular systole and to 2 to 5 mm Hg in skeletal muscle during exercise or ischemic stress.37,38
The ability for myoglobin dependent reduction of nitrite to modulate respiration has physiological implications for cellular respiration. In cardiac tissue and skeletal muscle, myoglobin is closely associated with mitochondria and acts as an oxygen reservoir for the organelle.39,40 This association has generated long-standing questions about other mechanisms of crosstalk existing between myoglobin and mitochondria. For example, some have speculated that scavenging of NO by myoglobin in the heart is a major mechanism of regulation of mitochondrial function.39 Here we have shown that as a nitrite reductase, myoglobin may play the role of an NO generator, instead of scavenger, to regulate hypoxic mitochondrial respiration. Interestingly, the km for oxygen binding of cytochrome c oxidase (0.4 to 1 µmol/L),41 below which the enzyme becomes oxygen limited, is lower than the P50 of myoglobin (3.1 µmol/L).40 This is important for the delivery of oxygen from myoglobin’s reserve to the mitochondria, but also has implications for the nitrite-myoglobin dependent regulation of mitochondrial function. According to this paradigm, myoglobin deoxygenates and is able to reduce nitrite to bioactive NO before mitochondria become oxygen limited. Thus, the NO formed from nitrite reduction can inhibit respiring mitochondria to conserve tissue oxygen, allowing diffusion of oxygen deeper into tissue (extension of oxygen gradients).
Whereas these data describe a role for myoglobin as a nitrite reductase that regulates mitochondrial respiration, they also highlight the potential for other heme-proteins, such as neuroglobin and cytoglobin, to be involved in hypoxic NO generation. These data also suggest that other NO-dependent processes may be regulated by nitrite reduction. Further investigation is needed to compare the relative efficiency of different heme proteins as nitrite reductases and characterize the physiological processes they modulate.
|
Acknowledgments |
|---|
Sources of Funding
Victor M. Darley-Usmar is funded by NIH grant HL58031. This work was supported by the NHLBI DIR.
Disclosures
Mark T. Gladwin is named as a co-inventor on a provisional NIH patent for the use of sodium salt in cardiovascular disease.
|
Footnotes |
|---|
*These authors contributed equally to this work.
Original received October 25, 2006; revision received January 19, 2007; accepted January 25, 2007.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO, 3rd, Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003; 9: 1498–1505.[CrossRef][Medline] [Order article via Infotrieve]
2. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD, Jr., Kraus D, Ho C, Gladwin MT, Patel RP. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood. 2006; 107: 566–574.
3. Lundberg JO, Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol. 2005; 25: 915–922.
4. Nagababu E, Ramasamy S, Abernethy DR, Rifkind JM. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J Biol Chem. 2003; 278: 46349–46356.
5. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005; 115: 1232–1240.[CrossRef][Medline] [Order article via Infotrieve]
6. Webb A, Bond R, McLean P, Uppal R, Benjamin N, Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci U S A. 2004; 101: 13683–13688.
7. Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, Maloney RE, Bharti A, Rodriguez J, Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol. 2005; 1: 290–297.[CrossRef][Medline] [Order article via Infotrieve]
8. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem. 2001; 276: 24482–24489.
9. Castello PR, David PS, McClure T, Crook Z, Poyton RO. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab. 2006; 3: 277–287.[CrossRef][Medline] [Order article via Infotrieve]
10. Gautier C, van Faassen E, Mikula I, Martasek P, Slama-Schwok A. Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia. Biochem Biophys Res Commun. 2006; 341: 816–821.[CrossRef][Medline] [Order article via Infotrieve]
11. Lundberg JO, Weitzberg E, Lundberg JM, Alving K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut. 1994; 35: 1543–1546.
12. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med. 1995; 1: 804–809.[CrossRef][Medline] [Order article via Infotrieve]
13. Brooks J. The action of nitrite on hemoglobin in the absence of oxygen. Proc R Soc Med. 1937; 123: 368–382.
14. Doyle MP, Pickering RA, DeWeert TM, Hoekstra JW, Pater D. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem. 1981; 256: 12393–12398.
15. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, Gladwin MT. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest. 2005; 115: 2099–2107.[CrossRef][Medline] [Order article via Infotrieve]
16. Huang KT, Keszler A, Patel N, Patel RP, Gladwin MT, Kim-Shapiro DB, Hogg N. The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J Biol Chem. 2005; 280: 31126–31131.
17. Spencer NY, Zeng H, Patel RP, Hogg N. Reaction of S-nitrosoglutathione with the heme group of deoxyhemoglobin. J Biol Chem. 2000; 275: 36562–36567.
18. Brookes PS, Kraus DW, Shiva S, Doeller JE, Barone MC, Patel RP, Lancaster JR, Jr., Darley-Usmar V. Control of mitochondrial respiration by NO*, effects of low oxygen and respiratory state. J Biol Chem. 2003; 278: 31603–31609.
19. Shiva S, Brookes PS, Patel RP, Anderson PG, Darley-Usmar VM. Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc Natl Acad Sci U S A. 2001; 98: 7212–7217.
20. Thomas DD, Liu X, Kantrow SP, Lancaster JR, Jr. The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci U S A. 2001; 98: 355–360.
21. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science. 2003; 299: 896–899.
22. Brune B, Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr Med Chem. 2003; 10: 845–855.[CrossRef][Medline] [Order article via Infotrieve]
23. Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science. 2003; 302: 1975–1978.
24. Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci U S A. 2005; 102: 13147–13152.
25. Yamamura K, Steenbergen C, Murphy E. Protein kinase C and preconditioning: role of the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol. 2005; 289: H2484–H2490.
26. Angelo M, Singel DJ, Stamler JS. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc Natl Acad Sci U S A. 2006; 103: 8366–8371.
27. Nagababu E, Ramasamy S, Rifkind JM. S-nitrosohemoglobin: a mechanism for its formation in conjunction with nitrite reduction by deoxyhemoglobin. Nitric Oxide. 2006; 15: 20–29.[CrossRef][Medline] [Order article via Infotrieve]
28. Brown GC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta. 2001; 1504: 46–57.[Medline] [Order article via Infotrieve]
29. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994; 345: 50–54.[CrossRef][Medline] [Order article via Infotrieve]
30. Brookes PS, Salinas EP, Darley-Usmar K, Eiserich JP, Freeman BA, Darley-Usmar VM, Anderson PG. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem. 2000; 275: 20474–20479.
31. Brookes P, Darley-Usmar VM. Hypothesis: the mitochondrial NO(*) signaling pathway, and the transduction of nitrosative to oxidative cell signals: an alternative function for cytochrome C oxidase. Free Radic Biol Med. 2002; 32: 370–374.[CrossRef][Medline] [Order article via Infotrieve]
32. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys. 1996; 328: 85–92.[CrossRef][Medline] [Order article via Infotrieve]
33. Mason MG, Nicholls P, Wilson MT, Cooper CE. Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase. Proc Natl Acad Sci U S A. 2006; 103: 708–713.
34. Sarti P, Giuffre A, Forte E, Mastronicola D, Barone MC, Brunori M. Nitric oxide and cytochrome c oxidase: mechanisms of inhibition and NO degradation. Biochem Biophys Res Commun. 2000; 274: 183–187.[CrossRef][Medline] [Order article via Infotrieve]
35. Dweik RA, Laskowski D, Abu-Soud HM, Kaneko F, Hutte R, Stuehr DJ, Erzurum SC. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest. 1998; 101: 660–666.[Medline] [Order article via Infotrieve]
36. Shiva S, Wang X, Ringwood LA, Xu X, Yuditskaya S, Annavajjhala V, Miyajima H, Hogg N, Harris ZL, Gladwin MT. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol. 2006; 9: 486–493.[Medline] [Order article via Infotrieve]
37. Mole PA, Chung Y, Tran TK, Sailasuta N, Hurd R, Jue T. Myoglobin desaturation with exercise intensity in human gastrocnemius muscle. Am J Physiol. 1999; 277: R173–R180.[Medline] [Order article via Infotrieve]
38. Richardson RS, Newcomer SC, Noyszewski EA. Skeletal muscle intracellular PO(2) assessed by myoglobin desaturation: response to graded exercise. J Appl Physiol. 2001; 91: 2679–2685.
39. Brunori M. Nitric oxide, cytochrome-c oxidase and myoglobin. Trends Biochem Sci. 2001; 26: 21–23.[CrossRef][Medline] [Order article via Infotrieve]
40. Wittenberg JB, Wittenberg BA. Myoglobin function reassessed. J Exp Biol. 2003; 206: 2011–2020.
41. Gnaiger E, Kuznetsov AV. Mitochondrial respiration at low levels of oxygen and cytochrome c. Biochem Soc Trans. 2002; 30: 252–258.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  J. W. Calvert and D. J. Lefer Myocardial protection by nitrite Cardiovasc Res, July 15, 2009; 83(2): 195 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Gladwin and S. Shiva The Ligand Binding Battle at Cytochrome c Oxidase: How NO Regulates Oxygen Gradients in Tissue Circ. Res., May 22, 2009; 104(10): 1136 - 1138. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Vitturi, X. Teng, J. C. Toledo, S. Matalon, J. R. Lancaster Jr., and R. P. Patel Regulation of nitrite transport in red blood cells by hemoglobin oxygen fractional saturation Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1398 - H1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Perlman, S. M. Bauer, H. Ashrafian, N. S. Bryan, M. F. Garcia-Saura, C. C. Lim, B. O. Fernandez, G. Infusini, M. E. McComb, C. E. Costello, et al. Mechanistic Insights Into Nitrite-Induced Cardioprotection Using an Integrated Metabolomic/Proteomic Approach Circ. Res., March 27, 2009; 104(6): 796 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kato and M. T. Gladwin Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy JAMA, December 10, 2008; 300(22): 2638 - 2646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Feelisch, B. O. Fernandez, N. S. Bryan, M. F. Garcia-Saura, S. Bauer, D. R. Whitlock, P. C. Ford, D. R. Janero, J. Rodriguez, and H. Ashrafian Tissue Processing of Nitrite in Hypoxia: AN INTRICATE INTERPLAY OF NITRIC OXIDE-GENERATING AND -SCAVENGING SYSTEMS J. Biol. Chem., December 5, 2008; 283(49): 33927 - 33934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hazarika, M. Angelo, Y. Li, A. J. Aldrich, S. I. Odronic, Z. Yan, J. S. Stamler, and B. H. Annex Myocyte Specific Overexpression of Myoglobin Impairs Angiogenesis After Hind-Limb Ischemia Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2144 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gupta, A. S. Baghel, S. Bansal, T. K. Tyagi, R. Kumari, N. K. Saini, P. Ponnan, A. Kumar, M. Bose, D. Saluja, et al. Establishment of Glutamine Synthetase of Mycobacterium smegmatis as a Protein Acetyltransferase utilizing Polyphenolic Acetates as the Acetyl Group Donors J. Biochem., December 1, 2008; 144(6): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Basu, N. A. Azarova, M. D. Font, S. B. King, N. Hogg, M. T. Gladwin, S. Shiva, and D. B. Kim-Shapiro Nitrite Reductase Activity of Cytochrome c J. Biol. Chem., November 21, 2008; 283(47): 32590 - 32597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. McNulty, S. Scott, V. Kehoe, M. Kozak, L. I. Sinoway, and J. Li Nitrite consumption in ischemic rat heart catalyzed by distinct blood-borne and tissue factors Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2143 - H2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Webb, A. B. Milsom, K. S. Rathod, W. L. Chu, S. Qureshi, M. J. Lovell, F. M.J. Lecomte, D. Perrett, C. Raimondo, E. Khoshbin, et al. Mechanisms Underlying Erythrocyte and Endothelial Nitrite Reduction to Nitric Oxide in Hypoxia: Role for Xanthine Oxidoreductase and Endothelial Nitric Oxide Synthase Circ. Res., October 24, 2008; 103(9): 957 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Caretti, P. Bianciardi, R. Ronchi, M. Fantacci, M. Guazzi, and M. Samaja Phosphodiesterase-5 Inhibition Abolishes Neuron Apoptosis Induced by Chronic Hypoxia Independently of Hypoxia-Inducible Factor-1{alpha} Signaling Experimental Biology and Medicine, October 1, 2008; 233(10): 1222 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Gladwin and D. B. Kim-Shapiro The functional nitrite reductase activity of the heme-globins Blood, October 1, 2008; 112(7): 2636 - 2647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Alzawahra, M. A. H. Talukder, X. Liu, A. Samouilov, and J. L. Zweier Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H499 - H508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Minneci, K. J. Deans, S. Shiva, H. Zhi, S. M. Banks, S. Kern, C. Natanson, S. B. Solomon, and M. T. Gladwin Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H743 - H754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Lundberg and E. Weitzberg Nitrite reduction to nitric oxide in the vasculature Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H477 - H478. [Full Text] [PDF]
|
|
|
|
 |
|
 U. B. Hendgen-Cotta, M. W. Merx, S. Shiva, J. Schmitz, S. Becher, J. P. Klare, H.-J. Steinhoff, A. Goedecke, J. Schrader, M. T. Gladwin, et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury PNAS, July 22, 2008; 105(29): 10256 - 10261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Castello, D. K. Woo, K. Ball, J. Wojcik, L. Liu, and R. O. Poyton Reactive Oxygen Species Special Feature: Oxygen-regulated isoforms of cytochrome c oxidase have differential effects on its nitric oxide production and on hypoxic signaling PNAS, June 17, 2008; 105(24): 8203 - 8208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Gonzalez, S. Shiva, P. S. Vincent, L. A. Ringwood, L.-Y. Hsu, Y. Y. Hon, A. H. Aletras, R. O. Cannon III, M. T. Gladwin, and A. E. Arai Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction Circulation, June 10, 2008; 117(23): 2986 - 2994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Frerart, P. Sonveaux, G. Rath, A. Smoos, A. Meqor, N. Charlier, B. F. Jordan, J. Saliez, A. Noel, C. Dessy, et al. The Acidic Tumor Microenvironment Promotes the Reconversion of Nitrite into Nitric Oxide: Towards a New and Safe Radiosensitizing Strategy Clin. Cancer Res., May 1, 2008; 14(9): 2768 - 2774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Webb, N. Patel, S. Loukogeorgakis, M. Okorie, Z. Aboud, S. Misra, R. Rashid, P. Miall, J. Deanfield, N. Benjamin, et al. Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite Hypertension, March 1, 2008; 51(3): 784 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Grubina, S. Basu, M. Tiso, D. B. Kim-Shapiro, and M. T. Gladwin Nitrite Reductase Activity of Hemoglobin S (Sickle) Provides Insight into Contributions of Heme Redox Potential Versus Ligand Affinity J. Biol. Chem., February 8, 2008; 283(6): 3628 - 3638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Gladwin Evidence Mounts That Nitrite Contributes to Hypoxic Vasodilation in the Human Circulation Circulation, February 5, 2008; 117(5): 594 - 597. [Full Text] [PDF]
|
|
|
|
|
|
V. P. Cokic, S. A. Andric, S. S. Stojilkovic, C. T. Noguchi, and A. N. Schechter Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells Blood, February 1, 2008; 111(3): 1117 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chu, A. Breite, P. Ciraolo, R. S. Franco, and P. S. Low Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties Blood, January 15, 2008; 111(2): 932 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Palacios-Callender, V. Hollis, M. Mitchison, N. Frakich, D. Unitt, and S. Moncada Cytochrome c oxidase regulates endogenous nitric oxide availability in respiring cells: A possible explanation for hypoxic vasodilation PNAS, November 20, 2007; 104(47): 18508 - 18513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dejam, C. J. Hunter, C. Tremonti, R. M. Pluta, Y. Y. Hon, G. Grimes, K. Partovi, M. M. Pelletier, E. H. Oldfield, R. O. Cannon III, et al. Nitrite Infusion in Humans and Nonhuman Primates: Endocrine Effects, Pharmacokinetics, and Tolerance Formation Circulation, October 16, 2007; 116(16): 1821 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Jensen Nitric oxide formation from nitrite in zebrafish J. Exp. Biol., October 1, 2007; 210(19): 3387 - 3394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Isbell, M. T. Gladwin, and R. P. Patel Hemoglobin oxygen fractional saturation regulates nitrite-dependent vasodilation of aortic ring bioassays Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2565 - H2572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Murphy and C. Steenbergen Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury Cardiovasc Res, August 1, 2007; 75(3): 478 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Brown and V. Borutaite Nitric oxide and mitochondrial respiration in the heart Cardiovasc Res, July 15, 2007; 75(2): 283 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dezfulian, N. Raat, S. Shiva, and M. T. Gladwin Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics Cardiovasc Res, July 15, 2007; 75(2): 327 - 338. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||